• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人诱导多能干细胞源性神经元和组织中病理性 α-突触核蛋白聚集物的检测。

Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue.

机构信息

The Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

STAR Protoc. 2021 Mar 6;2(1):100372. doi: 10.1016/j.xpro.2021.100372. eCollection 2021 Mar 19.

DOI:10.1016/j.xpro.2021.100372
PMID:33733241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7941090/
Abstract

The accumulation of proteins into insoluble aggregates is a common feature of several neurodegenerative diseases. Aggregated α-synuclein is a major component of Lewy bodies that pathologically define Parkinson's disease (PD). Here, we present methods for the detection of pathogenic conformations of α-synuclein in induced pluripotent stem cell (iPSC) patient-derived neuron models and brain tissue. These methods can be applied to studies of PD pathogenesis and the discovery of novel therapeutics that restore physiological α-synuclein. For complete details on the use and execution of this protocol, please refer to Cuddy et al. (2019) and Zunke et al. (2018).

摘要

蛋白质聚集成不溶性聚集体是几种神经退行性疾病的共同特征。聚集的α-突触核蛋白是路易体的主要成分,路易体病理性地定义了帕金森病(PD)。在这里,我们介绍了在诱导多能干细胞(iPSC)患者来源的神经元模型和脑组织中检测α-突触核蛋白致病构象的方法。这些方法可用于研究 PD 的发病机制和发现恢复生理α-突触核蛋白的新型治疗方法。有关该方案使用和执行的完整详细信息,请参阅 Cuddy 等人(2019 年)和 Zunke 等人(2018 年)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1761/7941090/da4ba1473d6b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1761/7941090/590ebb5ecbc7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1761/7941090/da4ba1473d6b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1761/7941090/590ebb5ecbc7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1761/7941090/da4ba1473d6b/gr1.jpg

相似文献

1
Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue.人诱导多能干细胞源性神经元和组织中病理性 α-突触核蛋白聚集物的检测。
STAR Protoc. 2021 Mar 6;2(1):100372. doi: 10.1016/j.xpro.2021.100372. eCollection 2021 Mar 19.
2
Patient-specific pluripotent stem cell-based Parkinson's disease models showing endogenous alpha-synuclein aggregation.基于患者特异性多能干细胞的帕金森病模型显示内源性α-突触核蛋白聚集。
BMB Rep. 2019 Jun;52(6):349-359. doi: 10.5483/BMBRep.2019.52.6.142.
3
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.帕金森病患者外周α-突触核蛋白聚集物缺乏致病潜能。
Acta Neuropathol Commun. 2018 Feb 8;6(1):8. doi: 10.1186/s40478-018-0509-1.
4
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.检测毒性 α-突触核蛋白作为帕金森病生物标志物的方法。
Crit Rev Clin Lab Sci. 2020 Aug;57(5):291-307. doi: 10.1080/10408363.2019.1711359. Epub 2020 Mar 1.
5
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.与 PARK2 iPSC 来源神经元和死后脑组织中氧化应激增加和 α-突触核蛋白积累相关的线粒体功能障碍。
Mol Brain. 2012 Oct 6;5:35. doi: 10.1186/1756-6606-5-35.
6
C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.C 端截短加剧 α-突触核蛋白的聚集和细胞毒性:帕金森病的恶性循环。
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3714-3725. doi: 10.1016/j.bbadis.2018.10.003. Epub 2018 Oct 2.
7
Cellular models of alpha-synuclein toxicity and aggregation.α-突触核蛋白毒性和聚集的细胞模型。
J Neurochem. 2019 Sep;150(5):566-576. doi: 10.1111/jnc.14806. Epub 2019 Jul 30.
8
Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.突触前α-突触核蛋白聚集体而非路易小体导致路易体痴呆中的神经退行性变。
J Neurosci. 2007 Feb 7;27(6):1405-10. doi: 10.1523/JNEUROSCI.4564-06.2007.
9
Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.家族性帕金森病患者诱导多能干细胞衍生的多巴胺能神经元显示α-突触核蛋白病理学和异常的线粒体形态。
Cells. 2021 Sep 13;10(9):2402. doi: 10.3390/cells10092402.
10
A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.一种简单、通用且稳健的基于离心的过滤方案,用于分离和定量α-突触核蛋白单体、寡聚体和纤维:提高 α-突触核蛋白研究中的实验可重复性。
J Neurochem. 2020 Apr;153(1):103-119. doi: 10.1111/jnc.14955. Epub 2020 Feb 25.

引用本文的文献

1
Recombinant cathepsins B and L promote α-synuclein clearance and restore lysosomal function in human and murine models with α-synuclein pathology.重组组织蛋白酶B和L可促进α-突触核蛋白的清除,并在患有α-突触核蛋白病理学的人类和小鼠模型中恢复溶酶体功能。
Mol Neurodegener. 2025 Aug 29;20(1):95. doi: 10.1186/s13024-025-00886-1.
2
Vimentin network dysregulation mediates neurite deficits in duplication Parkinson's patient-derived midbrain neurons.波形蛋白网络失调介导了帕金森病患者来源的中脑神经元复制中的神经突缺陷。
Sci Adv. 2025 Jun 6;11(23):eadq2742. doi: 10.1126/sciadv.adq2742.
3
α-Synuclein Pathology Spreads in a Midbrain-Hindbrain Assembloid Model.

本文引用的文献

1
Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein.应激诱导的细胞清除作用是由 SNARE 蛋白 ykt6 介导的,α-突触核蛋白使其受到干扰。
Neuron. 2019 Dec 4;104(5):869-884.e11. doi: 10.1016/j.neuron.2019.09.001. Epub 2019 Oct 21.
2
Modeling neuronopathic storage diseases with patient-derived culture systems.利用患者来源的培养系统对神经病变性贮积病进行建模。
Neurobiol Dis. 2019 Jul;127:147-162. doi: 10.1016/j.nbd.2019.01.018. Epub 2019 Feb 19.
3
Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide.
α-突触核蛋白病理学在中脑-后脑类器官模型中扩散。
Adv Sci (Weinh). 2025 May;12(20):e2409040. doi: 10.1002/advs.202409040. Epub 2025 Apr 17.
4
Protocol for generation of PD modeling induced neurons and detection of α-synuclein forms.帕金森病建模诱导神经元的生成及α-突触核蛋白形式检测方案
STAR Protoc. 2024 Dec 20;5(4):103447. doi: 10.1016/j.xpro.2024.103447. Epub 2024 Nov 15.
5
Modeling Parkinson's disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines.通过依次暴露于α-突触核蛋白原纤维和促炎细胞因子在人多巴胺能神经元中模拟帕金森病病理学。
Nat Neurosci. 2024 Dec;27(12):2401-2416. doi: 10.1038/s41593-024-01775-4. Epub 2024 Oct 8.
6
CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.CHCHD2突变小鼠表现出线粒体蛋白质积累和能量代谢紊乱。
bioRxiv. 2024 Aug 31:2024.08.30.610586. doi: 10.1101/2024.08.30.610586.
7
Alpha-synuclein shapes monocyte and macrophage cell biology and functions by bridging alterations of autophagy and inflammatory pathways.α-突触核蛋白通过连接自噬和炎症途径的改变来塑造单核细胞和巨噬细胞的细胞生物学及功能。
Front Cell Dev Biol. 2024 Jul 5;12:1421360. doi: 10.3389/fcell.2024.1421360. eCollection 2024.
8
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson's disease patient iPSC derived midbrain neurons.己糖胺生物合成途径挽救帕金森病患者 iPSC 衍生中脑细胞溶酶体功能障碍。
Nat Commun. 2024 Jun 19;15(1):5206. doi: 10.1038/s41467-024-49256-3.
9
Nuclear aggregates of NONO/SFPQ and A-to-I-edited RNA in Parkinson's disease and dementia with Lewy bodies.帕金森病和路易体痴呆中 NONO/SFPQ 核聚体和 A-to-I 编辑 RNA
Neuron. 2024 Aug 7;112(15):2558-2580.e13. doi: 10.1016/j.neuron.2024.05.003. Epub 2024 May 17.
10
Mutant α-synuclein causes death of human cortical neurons via ERK1/2 and JNK activation.突变的α-突触核蛋白通过 ERK1/2 和 JNK 的激活导致人皮质神经元死亡。
Mol Brain. 2024 Mar 5;17(1):14. doi: 10.1186/s13041-024-01086-6.
葡萄糖神经酰胺导致 α-突触核蛋白发生可逆构象转换,形成毒性聚集体。
Neuron. 2018 Jan 3;97(1):92-107.e10. doi: 10.1016/j.neuron.2017.12.012. Epub 2017 Dec 28.
4
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.
5
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.在人类中脑突触核蛋白病模型中,α-突触核蛋白诱导的溶酶体功能障碍是通过蛋白质运输的破坏而发生的。
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1931-6. doi: 10.1073/pnas.1520335113. Epub 2016 Feb 2.
6
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.将外源性α-突触核蛋白原纤维添加到原代神经元培养物中,以引发内源性α-突触核蛋白募集到路易小体和路易神经突样聚集体中。
Nat Protoc. 2014 Sep;9(9):2135-46. doi: 10.1038/nprot.2014.143. Epub 2014 Aug 14.
7
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.人胚胎干细胞衍生的多巴胺神经元在帕金森病动物模型中有效移植。
Nature. 2011 Nov 6;480(7378):547-51. doi: 10.1038/nature10648.
8
Improved immunodetection of endogenous α-synuclein.增强内源性 α-突触核蛋白的免疫检测。
PLoS One. 2011;6(8):e23939. doi: 10.1371/journal.pone.0023939. Epub 2011 Aug 19.
9
Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration.A53T 转基因小鼠中特定区域的α-突触核蛋白寡聚物:对神经退行性变的影响。
J Neurosci. 2010 Mar 3;30(9):3409-18. doi: 10.1523/JNEUROSCI.4977-09.2010.
10
Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.胞质儿茶酚抑制α-突触核蛋白聚集,并促进细胞内可溶性寡聚中间体的形成。
J Neurosci. 2006 Sep 27;26(39):10068-78. doi: 10.1523/JNEUROSCI.0896-06.2006.